SESSION TYPE: Sleep Posters
PRESENTED ON: Wednesday, October 24, 2012 at 01:30 PM - 02:30 PM
PURPOSE: CPAP Therapy is an effectice therapy for OSA. The purpose of this study was to determine patient/therapist contact time would increase patient CPAP compliance.
METHODS: Retrospective chart review of patients diagnosed with OSA with the portable monitoring device ARES and treated with CPAP from the Sleep Center opening to February 2012. CPAP compliance data tracked via data download. Patient contact time included a total of 3 sessions: Each session included one on one contact time, education and discussion on OSA. Day 1: A 60 minute review of patient completion of a Sleep History, Health and Epworth Sleepiness Scale Questionnaires, proper fitting and instructions on use of the PM device ARES. Day 2: A 60 minute review of data from the PM device ARES downloaded to the computer assisted analysis software, review the data with the patient, properly fit appropriate CPAP interface device and place patient on AutoCPAP trial for 15 minutes, and provide a 10 minute educational video on OSA. Day 3: A 10 minute review of the AutoCPAP device, patient completed questionnaire detailing experience with use of the AutoCPAP equipment. CPAP equipment ordered based on questionnaire answers. On day 30: A 30 minute CPAP Compliance Evaluation review. Data was downloaded from patients CPAP Equipment to EncorePro 2 software for compliance tracking purposes and discussed with the patient. The Sleep Center utilized the Type 4 PM device ARES. The AutoCPAP device used was a Respironics Remstar Auto A-Flex.
RESULTS: Study criteria included a total of 64 patients >18 yrs of age. Excluded patients: A total of 25 patients: 1 patient CPAP therapy not indicated, 5 patients did not fill prescriptions provided, 12 patients did not show up for scheduled compliance evaluation review, 5 patients refused to complete the AutoCPAP titration study, 2 patients declined to use CPAP equipment. A total of 39 patients met the inclusion criteria (20 Male, 19 Female), Mean age: 56 ± 27, Mean Initial AHI 44 ± 39, Mean CPAP Therapy AHI 7 ± 7. CPAP Compliance determined by days of usage in the 30 day evaluation period: Overall CPAP Compliance Rate >75%.
CONCLUSIONS: It is concluded that comprehensive patient/therapist contact time of 150 minutes within 30 days of initiating CPAP therapy for the treatment of OSA is associated with increased CPAP Compliance after 1 month.
CLINICAL IMPLICATIONS: Our findings would support that inceased patient therapist contact time would increase CPAP compliance rates for patients diagnosed with OSA.
DISCLOSURE: The following authors have nothing to disclose: Sharon Ngan
No Product/Research Disclosure InformationKaiser Permanente, Lancaster, CA